TrialDiabetes care2010

Switching to once-daily liraglutide from twice-daily exenatide further improves glycemic control in patients with type 2 diabetes using oral agents.

John B Buse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.